These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19150063)

  • 21. Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load.
    Tsai MY; Georgopoulos A; Otvos JD; Ordovas JM; Hanson NQ; Peacock JM; Arnett DK
    Clin Chem; 2004 Jul; 50(7):1201-4. PubMed ID: 15142979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes.
    Ogawa S; Takeuchi K; Ito S
    Diabetes Obes Metab; 2004 Sep; 6(5):384-90. PubMed ID: 15287932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
    Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
    Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of influence of test meal fatty acid composition on the contribution of intestinally-derived lipoproteins to postprandial lipaemia.
    Jackson KG; Zampelas A; Knapper JM; Culverwell CC; Wright J; Gould BJ; Williams CM
    Br J Nutr; 1999 Jan; 81(1):51-7. PubMed ID: 10341676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
    Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
    J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.
    Westphal S; Orth M; Ambrosch A; Osmundsen K; Luley C
    Am J Clin Nutr; 2000 Apr; 71(4):914-20. PubMed ID: 10731497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired glucose tolerance is not associated with lipid intolerance.
    Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
    Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism.
    Hald EM; Brækkan SK; Vik A; Brodin EE; Hansen JB
    J Clin Lipidol; 2013; 7(1):48-55. PubMed ID: 23351583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE; Tighe AP; Sadovsky R; Davidson MH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low-protein diet exacerbates postprandial chylomicron concentration in moderately dyslipidaemic subjects in comparison to a lean red meat protein-enriched diet.
    Mamo JC; James AP; Soares MJ; Griffiths DG; Purcell K; Schwenke JL
    Eur J Clin Nutr; 2005 Oct; 59(10):1142-8. PubMed ID: 16015257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of exercise on postprandial lipidemia in type 2 diabetic patients.
    Tobin LW; Kiens B; Galbo H
    Eur J Appl Physiol; 2008 Feb; 102(3):361-70. PubMed ID: 17952452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome.
    Mangat R; Su J; Scott PG; Russell JC; Vine DF; Proctor SD
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):477-81. PubMed ID: 17511632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat.
    Morgado N; Rigotti A; Valenzuela A
    Ann Nutr Metab; 2005; 49(6):397-406. PubMed ID: 16227687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.
    Vine DF; Takechi R; Russell JC; Proctor SD
    Atherosclerosis; 2007 Feb; 190(2):282-90. PubMed ID: 16624317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial hyperlipidemia as a potential residual risk factor.
    Nakamura K; Miyoshi T; Yunoki K; Ito H
    J Cardiol; 2016 Apr; 67(4):335-9. PubMed ID: 26744235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.